PMID- 11979349 OWN - NLM STAT- MEDLINE DCOM- 20020620 LR - 20131121 IS - 1523-6838 (Electronic) IS - 0272-6386 (Linking) VI - 39 IP - 5 DP - 2002 May TI - Dialyzer fiber bundle volume and kinetics of solute removal in continuous venovenous hemodialysis. PG - 1047-53 AB - The relationship between dialyzer fiber bundle volume (FBV), dialyzer life span, and small-solute clearance has yet to be clearly defined in continuous venovenous hemodialysis (CVVHD). This study sought to define this relationship using novel ultrasound dilution technology. We studied 55 sessions in 31 intensive care unit patients on CVVHD therapy. A session was defined as the life span of a single dialyzer. The following variables were assessed every 6 hours throughout each session, starting within 1 hour of initiation of that session: FBV, access recirculation, extracorporeal blood flow rate, effluent (EUN) to blood urea nitrogen (BUN) concentration ratio, effluent creatinine to blood creatinine concentration ratio, and urea nitrogen and creatinine clearances. Data were analyzed using random-effects linear models to estimate trends. Several dialysis-related and solute-removal parameters were analyzed for association with each other. Systemic or dialysis circuit heparin was administered in 28 of 55 sessions. One hundred seventy sets of FBV, 101 sets of urea clearance, and 102 sets of creatinine clearance measurements were performed. There was a declining trend for FBV (0.8 mL/h), heart rate (0.25 beats/min/h), and measured blood flow (0.33 mL/min/h; P < 0.05). Apart from dialysate inflow rate (P = 0.044), there was no significant correlation with EUN-BUN ratio. Session duration was associated with dialysis access site; the femoral access provided longer dialysis sessions than subclavian and internal jugular accesses (P = 0.029). We conclude that small-solute removal remains stable over the course of our CVVHD system life spans despite significant loss of hemodialyzer FBV. CI - Copyright 2002 by the National Kidney Foundation, Inc. FAU - Liangos, Orfeas AU - Liangos O AD - Department of Nephrology/Hypertension, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. FAU - Sakiewicz, Paul G AU - Sakiewicz PG FAU - Kanagasundaram, Nigel S AU - Kanagasundaram NS FAU - Hammel, Jeff AU - Hammel J FAU - Pajouh, Mehdi AU - Pajouh M FAU - Seifert, Tracy AU - Seifert T FAU - Paganini, Emil P AU - Paganini EP LA - eng GR - DK 54556-01/DK/NIDDK NIH HHS/United States GR - R01 DK 53411-01/DK/NIDDK NIH HHS/United States GR - R01 DK 53411-02/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Am J Kidney Dis JT - American journal of kidney diseases : the official journal of the National Kidney Foundation JID - 8110075 RN - 0 (Hemodialysis Solutions) RN - 8W8T17847W (Urea) RN - AYI8EX34EU (Creatinine) RN - N762921K75 (Nitrogen) SB - IM MH - Blood Urea Nitrogen MH - Creatinine/blood/metabolism MH - Hemodialysis Solutions/analysis/metabolism MH - Hemofiltration/*instrumentation/*methods/statistics & numerical data MH - Humans MH - Kidney Failure, Chronic/blood/therapy MH - Kinetics MH - Metabolic Clearance Rate/physiology MH - Monitoring, Physiologic/instrumentation/methods/statistics & numerical data MH - Nitrogen/metabolism MH - Renal Circulation/physiology MH - Signal Processing, Computer-Assisted/instrumentation MH - Urea/metabolism EDAT- 2002/04/30 10:00 MHDA- 2002/06/21 10:01 CRDT- 2002/04/30 10:00 PHST- 2002/04/30 10:00 [pubmed] PHST- 2002/06/21 10:01 [medline] PHST- 2002/04/30 10:00 [entrez] AID - S0272-6386(02)10644-5 [pii] AID - 10.1053/ajkd.2002.32788 [doi] PST - ppublish SO - Am J Kidney Dis. 2002 May;39(5):1047-53. doi: 10.1053/ajkd.2002.32788.